Related Experiment Videos
An enzyme-linked immunoassay for thyroid microsomal antibodies.
Journal of Immunological Methods
|December 17, 1982
Summary
A new enzyme-linked immunoassay (ELISA) accurately detects microsomal antibodies in serum and lymphocyte cultures. This sensitive and precise method shows good correlation with existing tests and is valuable for autoimmune disease research.
Area of Science:
- Immunology
- Clinical Chemistry
Background:
- Microsomal antibodies are important biomarkers in autoimmune thyroid diseases.
- Conventional methods for detecting microsomal antibodies can be time-consuming and less sensitive.
Purpose of the Study:
- To describe and validate a novel enzyme-linked immunoassay (ELISA) for the detection of microsomal antibodies.
- To assess the sensitivity, precision, and specificity of the developed ELISA method.
Main Methods:
- Development of an enzyme-linked immunoassay (ELISA) for microsomal antibody detection.
- Analysis of 115 serum samples comparing ELISA with the tanned red cell haemagglutination test.
- Evaluation of potential interferences from other autoantibodies and analysis of lymphocyte cultures.
Main Results:
- The ELISA method demonstrated high sensitivity, precision, and speed.
- Excellent correlation was observed between the ELISA and the conventional haemagglutination test.
- The ELISA showed minimal interference from thyroglobulin antibody, rheumatoid factor, antinuclear factor, or gastric parietal cell antibodies, but a non-specific effect was noted with mitochondrial antibodies.
- The technique effectively analyzed microsomal antibody production in Hashimoto lymphocyte cultures, even without mitogen stimulation.
Conclusions:
- The developed ELISA is a reliable, sensitive, and precise method for quantifying microsomal antibodies.
- This ELISA technique is valuable for studying microsomal autoantibody activity in both serum and lymphocyte cultures, particularly in autoimmune thyroid disease research.
- The method's high capacity and sensitivity make it a significant advancement for clinical and research applications.